Brazil set to import cannabis in Espírito Santo

Espírito Santo is a state in Brazil. Its capital is Vitoria, and the largest city is Serra. With an extensive coastline, the state hosts some of the country’s main ports, and its beaches are significant tourist attractions. Tourism plays an ever-increasing role in the state although international tourism is rarer. This year, Espírito Santo decided to start importing cannabis products.

Geographical location and tax incentives have attracted the attention of the pharmaceutical industry to cannabis in Espírito Santo (ES).

This is after the regulation of the manufacture and sale of cannabis products in Brazil by the National Health Surveillance Agency (Anvisa).

Hemp.im is a mobile application that provides you with the most current and up-to-date hemp news and other cannabis industry information while covering various wide-ranging topics throughout the industry.

Attractive locations for cannabis in Espírito Santo

The cultivation of the plant remains forbidden in Brazilian territory. To overcome this obstacle, companies that settle in this market will need to import the products.

According to the State Health Secretariat (Sesa), 17 patients already receive medical cannabis in Espírito Santo.

“Patients with recommendation and prescription for the use of products with THC and/or CBD substances present in the plant will be able to buy the medicines directly in pharmacies,” concluded businessman Valter Luis Macedo de Carvalhaes Pinheiro.

Pharmaceutical cannabis in Espírito Santo

The entrepreneurs who work in the distribution of pharmaceutical and hospital drugs in the region chose the state of Espírito Santo to receive all their imports. Experts predict revenues above $1 billion (R$ 4 billion) in the next three years.

“There is an estimated tax collection on these drugs of more than $245 million (R$1 billion) per year. I am betting on the international trend where the medicinal use of the drug reaches billionaire figures,” he said, commenting on the process.

__

(Featured image by ivanbarbosa19971 via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in SECHAT, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.